[HTML][HTML] Sex differences in the inflammation-depression link: A systematic review and meta-analysis

DA Jarkas, AH Villeneuve, AZB Daneshmend… - Brain, behavior, and …, 2024 - Elsevier
Abstract Major Depressive Disorder (MDD) is a heterogeneous disorder that affects twice as
many women than men. Precluding advances in more tailored and efficacious treatments for …

C-reactive protein as a biomarker for major depressive disorder?

L Orsolini, S Pompili, S Tempia Valenta, V Salvi… - International journal of …, 2022 - mdpi.com
The etiopathogenesis of depression is not entirely understood. Several studies have
investigated the role of inflammation in major depressive disorder. The present work aims to …

[HTML][HTML] An inflamed subtype of difficult-to-treat depression

K Suneson, C Grudet, F Ventorp, J Malm, M Asp… - Progress in Neuro …, 2023 - Elsevier
Background Chronic low-grade inflammation may play a role in the pathophysiology of
depression, at least in a subset of patients. High-sensitivity C-reactive protein (hs-CRP) has …

[HTML][HTML] A novel biomarker of interleukin 6 activity and clinical and cognitive outcomes in depression

ÉM Foley, C Slaney, NA Donnelly, M Kaser… - …, 2024 - Elsevier
Background Inflammatory cytokines like interleukin-6 (IL-6) are implicated in depression, but
most studies have hitherto focused on circulating levels of IL-6 rather than its activity. IL-6 …

Variation of circulating brain-derived neurotrophic factor (BDNF) in depression: relationships with inflammatory indices, metabolic status and patients' clinical features

V Falaschi, L Palego, D Marazziti, L Betti, L Musetti… - Life, 2023 - mdpi.com
This study seeks to offer a contribution to the method of subtyping major depressed patients
by exploring the possible relationships between circulating brain-derived neurotrophic factor …

[HTML][HTML] Efficacy of inflammation-based stratification for add-on celecoxib or minocycline in major depressive disorder: Protocol of the INSTA-MD double-blind placebo …

C Wessa, J Janssens, V Coppens, K El Abdellati… - Brain, behavior, & …, 2024 - Elsevier
Introduction Different lines of evidence confirm the involvement of the immune system in the
pathophysiology of major depressive disorder. Up to 30% of depressed patients present with …

Omega-3 polyunsaturated fatty acids (n-3 PUFAs), somatic and fatigue symptoms in cardiovascular diseases comorbid major depressive disorder (MDD): A …

JPC Chang, SS Chang, HT Chen, YC Chien… - Brain, behavior, and …, 2023 - Elsevier
Abstract Introduction Cardiovascular diseases (CVDs) and major depressive disorder (MDD)
are the two most disabling diseases. Patients with CVDs comorbid depression had somatic …

[HTML][HTML] Importance of immunometabolic markers for the classification of patients with major depressive disorder using machine learning

Y Sánchez-Carro, A de la Torre-Luque… - Progress in Neuro …, 2023 - Elsevier
Background Although there is scientific evidence of the presence of immunometabolic
alterations in major depression, not all patients present them. Recent studies point to the …

[HTML][HTML] Towards a consensus roadmap for a new diagnostic framework for mental disorders

MJH Kas, S Hyman, LM Williams… - European …, 2025 - Elsevier
Current nosology claims to separate mental disorders into distinct categories that do not
overlap with each other. This nosological separation is not based on underlying …

Sex-specific associations between levels of high-sensitivity C-reactive protein and severity of depression: retrospective cross-sectional analysis of inpatients in China

B Chen, J Dong, W Guo, T Li - BMC psychiatry, 2024 - Springer
Background We aimed to clarify the controversial relationship between levels of high-
sensitivity C-reactive protein (hs-CRP) and severity of depression in men and women …